Progresses of immunomodulatory therapy in sever acute pancreatitis / 中华危重病急救医学
Chinese Critical Care Medicine
;
(12): 954-957, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-661791
ABSTRACT
Severe acute pancreatitis (SAP) is accompanied with complex pathogenic course and high mortality. The imbalance of immune response is an important cause which leads the SAP patients to the severe situation and even death. The immunomodulatory therapy can regulate the imbalance of inflammation, alleviate SAP-associated organ injury, and improve the prognosis of patients. Previous immunomodulatory therapy had some problems, such as single-object and simple-method. In recent years, some new methods of immunomodulatory therapy, such as regulating the apoptosis and mature of immune cells, applying of mesenchymal stem cells (MSCs) and multi-regulation methods, provide some new ideas and hopes for SAP therapy. This paper reviewed the history and recent research progresses of SAP immunomodulatory therapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Chinese Critical Care Medicine
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS